Pia Vaassen
Duisburg, NW 47055, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Diagnoses of double heterozygous NF1 variants and dual RASopathy.
Journal: Molecular and cellular pediatrics
Published: October 07, 2025
Mitogen-Activated Proteinkinase Kinase Inhibition Results in Rapid and Dramatic Shrinkage of a Facial Plexiform Neurofibroma in a 6-Month-Old Infant.
Journal: Pediatric neurology
Published: September 15, 2025
Age-Adapted Diagnostic Evaluation and Treatment of Patients With Type 1 Neurofibromatosis in Germany.
Journal: Deutsches Arzteblatt international
Published: August 09, 2024
Correction to: A chance to cut is a chance to cure: complete resection of an atypical neurofibroma prevents further progression to malignancy.
Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
Published: July 29, 2023
A chance to cut is a chance to cure: complete resection of an atypical neurofibroma prevents further progression to malignancy.
Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
Published: May 02, 2023
Treatment of Plexiform Neurofibromas with MEK Inhibitors: First Results with a New Therapeutic Option.
Journal: Neuropediatrics
Published: December 14, 2021
Trametinib Induces Neurofibroma Shrinkage and Enables Surgery.
Journal: Neuropediatrics
Published: May 30, 2019
Nevus Anemicus As an Additional Diagnostic Marker of Neurofibromatosis Type 1 in Childhood.
Journal: Neuropediatrics
Published: March 29, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026